HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Targeting of Rac GTPases blocks the spread of intact human breast cancer.

Abstract
High expression of Rac small GTPases in invasive breast ductal carcinoma is associated with poor prognosis, but its therapeutic value in human cancers is not clear. The aim of the current study was to determine the response of human primary breast cancers to Rac-based drug treatments ex vivo. Three-dimensional organotypic cultures were used to assess candidate therapeutic avenues in invasive breast cancers. Uniquely, in these primary cultures, the tumour is not disaggregated, with both epithelial and mesenchymal components maintained within a 3-dimensional matrix of type I collagen. EHT 1864, a small molecule inhibitor of Rac GTPases, prevents spread of breast cancers in this setting, and also reduces proliferation at the invading edge. Rac1+ epithelial cells in breast tumours also contain high levels of the phosphorylated form of the transcription factor STAT3. The small molecule Stattic inhibits activation of STAT3 and induces effects similar to those seen with EHT 1864. Pan-Rac inhibition of proliferation precedes down-regulation of STAT3 activity, defining it as the last step in Rac activation during human breast cancer invasion. Our data highlights the potential use of Rac and STAT3 inhibition in treatment of invasive human breast cancer and the benefit of studying novel cancer treatments using 3-dimensional primary tumour tissue explant cultures.
AuthorsElad Katz, Andrew H Sims, Duncan Sproul, Helen Caldwell, Michael J Dixon, Richard R Meehan, David J Harrison
JournalOncotarget (Oncotarget) Vol. 3 Issue 6 Pg. 608-19 (Jun 2012) ISSN: 1949-2553 [Electronic] United States
PMID22689141 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • EHT 1864
  • Pyrones
  • Quinolines
  • RAC1 protein, human
  • STAT3 Transcription Factor
  • STAT3 protein, human
  • rac1 GTP-Binding Protein
Topics
  • Apoptosis (drug effects)
  • Breast Neoplasms (drug therapy, genetics, metabolism, pathology)
  • Carcinoma, Ductal, Breast (drug therapy, genetics, metabolism, pathology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Down-Regulation
  • Female
  • Humans
  • Molecular Targeted Therapy
  • Pyrones (pharmacology)
  • Quinolines (pharmacology)
  • STAT3 Transcription Factor (antagonists & inhibitors)
  • Signal Transduction (drug effects)
  • rac1 GTP-Binding Protein (antagonists & inhibitors, biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: